Science News from #ISC26
Sessions: February 4–6, 2026
Ernest N. Morial Convention Center | New Orleans, Louisiana
Understand the science from #ISC26
Dive into the details of the most exciting late-breaking science presented during the International Stroke Conference 2026. Starting on Wednesday, Feb. 3, 2026, you'll find links to video interviews with presenting investigators and American Heart Association professional volunteers, along with data summaries and conclusions.
Find all of the content you need right here.
2026 Important Links
Programming
- #ISC26 Abstracts in Stroke – Science abstracts (except Late-Breaking Science)
- Articles published Simultaneously in AHA Journals
- 2026 Online Program Planner site – Abstracts, schedules, and more
- Late-Breaking Science – Top trial results
- Virtual Programming – Watch or rewatch sessions
- CE Credit – Instructions on how to claim credit
While On-Site
- For Presenters & Moderators – details and how-to instructions
- Mobile Meeting Guide App ‐ #ISC26 on your phone
- American Heart Association Newsroom – news releases
- #ISC26 Science News – in-depth interviews with presenting investigators, data slides
- ISC Conference Coverage
- ISC Daily News (newspaper)
Guidelines and references
CHOICE2
The Chemical Optimization of Cerebral Embolectomy Trial: Main Results
Angel Chamorro | Hospital Clinic Barcelona, Barcelona, Spain
RESULTS: Intra-arterial alteplase following successful thrombectomy was associated with increased rates of excellent functional outcome, supporting its use in appropriately selected patients.
FASTEST
Recombinant Factor VIIa for Spontaneous Intracerebral Hemorrhage within Two Hours of Onset
Joseph P Broderick | University of Cincinnati, Cincinnati, OH
RESULTS: rFVIIa slowed growth of hematoma when administered within 2 hours of ICH symptom onset in patients with a spot sign but had slightly increased risk for life-threatening thromboembolic complications and did not improve overall functional outcomes when compared to placebo.
CREST-2
The Effect of Treatment on Cognitive Function in Patients with Asymptomatic Carotid Artery Stenosis
Ronald M Lazar | University of Alabama at Birmingham, Birmingham, AL
RESULTS: Neither the addition of CAS nor CEA demonstrated cognitive benefit compared to IMM alone, including in patients with worse baseline cognition.
